Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Michio Inukai"'
Autor:
Takashi Himoto, Hirohito Yoneyama, Kazutaka Kurokohchi, Michio Inukai, Hisashi Masugata, Fuminori Goda, Reiji Haba, Seishiro Watanabe, Shoichi Senda, Tsutomu Masaki
Publikováno v:
Canadian Journal of Gastroenterology, Vol 26, Iss 3, Pp 125-129 (2012)
Mutations in the p53 gene leading to conformational changes in the p53 protein have been well established in many human cancers. Conformational changes and/or cellular accumulation of the protein may induce an immune response, resulting in circulatin
Externí odkaz:
https://doaj.org/article/6d1bc78585a246098777e53861dcfb90
Autor:
Michio, Inukai, Akiko, Ohara, Junichiro, Nasu, Haruyuki, Kawai, Kazuhiko, Watanabe, Hiroto, Watanabe, Atsuko, Inaba
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(7)
Weight loss during cancer chemotherapy affects the continuation of treatment; therefore, it is important to maintain and improve nutritional status. Additionally, appropriate fluid and electrolyte replacement is essential for maintaining life. This s
Autor:
Akihito Tsuji, Satoshi Kaihara, Michio Inukai, Takanori Watanabe, Toshihiko Matsumoto, Masahito Kotaka, Hiroki Hashida, Yasuhiro Miyake, Hiroaki Tanioka, Hisateru Yasui, Masato Matsuura, Shinichi Yoshioka, Yoshihiro Okita, Takeshi Kotake, Takahisa Kyogoku, Takeshi Kato, Hironaga Satake
Publikováno v:
The Oncologist
Lessons Learned Background The role of neoadjuvant and adjuvant chemotherapy in the management of initially resectable colorectal cancer liver metastases (CLM) is still unclear. We evaluated the feasibility of 3-month adjuvant treatment with capecita
Autor:
Takashi Kikuchi, Hiroaki Nagano, Michio Inukai, Tomohiro Nishina, Ichiro Moriyama, Takeshi Shiraishi, Hiroaki Tanioka, Ryosuke Yoshida, Kenji Tsuchihashi, Kimiyasu Nozaka, Michiya Kobayashi, Yasuro Kurisu, Toshiyoshi Fujiwara, Masashi Miguchi, Takeshi Nagasaka, K. Shinozaki, Toshihiko Matsumoto, Yasuhiro Yuasa, Takeshi Yamada, Junichiro Nasu
Publikováno v:
International Journal of Clinical Oncology
Purpose FOLFOXIRI plus bevacizumab is regarded as a first-line therapeutic option for selected patients with metastatic colorectal cancer (mCRC). Our aim was to assess the efficacy and safety of induction treatment with FOLFOXIRI plus bevacizumab in
Autor:
Michio Inukai, S. Kaihara, Shinichi Yoshioka, Masato Matsuura, T. Kyogoku, Hisateru Yasui, Yasuhiro Miyake, Akihito Tsuji, Yoshihiro Okita, Toshihiko Matsumoto, Takeshi Kotake, T. Kato, T. Watanabe, Hironaga Satake, Masahito Kotaka, Hiroaki Tanioka, H. Hashida
Publikováno v:
Annals of Oncology. 32:S165-S166
Autor:
Hiroaki Tanioka, Masashi Miguchi, Kenji Tsuchihashi, Takashi Kikuchi, Michiya Kobayashi, Toshihiko Matsumoto, Takeshi Shiraishi, Ryosuke Yoshida, Yasuro Kurisu, Katsunori Shinozaki, Ichiro Moriyama, Junichiro Nasu, Tomohiro Nishina, Takeshi Nagasaka, Toshiyoshi Fujiwara, Hiroaki Nagano, Takeshi Yamada, Michio Inukai, Yasuhiro Yuasa, Kimiyasu Nosaka
Publikováno v:
Journal of Clinical Oncology. 38:134-134
134 Background: FOLFOXIRI-Bmab has been recognized as one of the standard first-line treatments for mCRC. We conducted a single arm, multicenter, phase II study to assess the efficacy and safety of FOLFOXIRI-Bmab in pts with untreated mCRC harboring
Autor:
Nobuya Ishibashi, Naruo Kawasaki, Michio Maruyama, Tetsuharu Oriishi, Yutaka Suzuki, Takashi Higashiguchi, Etsuko Nakamura, Isao Tabei, Shohei Iijima, Naomi Kurata, Michio Inukai, Masahiro Chiba
Publikováno v:
Annals of nutritionmetabolism. 73(3)
Background/Aims: The current study was undertaken to assess if the semi-solid formulas could be used with a new ENFit connector with similar force to current percutaneous endoscopic gastrostomy (PEG) tubes. Methods: Experiment 1: We measured the appl
Autor:
Shigeyoshi Iwamoto, Yoshinori Munemoto, Kenji Ina, Tadamichi Denda, Katsuyuki Kunieda, Masaki Nakamura, Kiyotaka Kurachi, Takeshi Kato, Mitsuru Ooshiro, Yoshitaka Morita, Tatsu Shimoyama, Takao Takahashi, Hiroshi Tamagawa, Nobuhiko Nagata, Hideyuki Mishima, Junichi Sakamoto, Taishi Hata, Hideo Baba, Michio Inukai, Koji Oba
Publikováno v:
Annals of Oncology
EAGLE was a randomized, multicenter phase III study which evaluated the superiority of bevacizumab 10 mg/kg plus FOLFIRI compared with bevacizumab 5 mg/kg plus FOLFIRI in patients with mCRC previously treated with first-line bevacizumab plus an oxali
Autor:
Michio Inukai, Tomoki Yamatsuji, Masanori Yoshimitsu, Toshiki Yamakawa, Masazumi Okajima, Atsushi Tsuruta, Taketoshi Yamano, Kazuhiro Toyota, Kazuki Yamashita, Hiroaki Tanioka, Takeshi Nagasaka, Akihito Tsuji
Publikováno v:
Drug Design, Development and Therapy
Atsushi Tsuruta,1,* Kazuki Yamashita,2,* Hiroaki Tanioka,3 Akihito Tsuji,4,5 Michio Inukai,6 Toshiki Yamakawa,7 Tomoki Yamatsuji,8 Masanori Yoshimitsu,9 Kazuhiro Toyota,10 Taketoshi Yamano,11 Takeshi Nagasaka,12 Masazumi Okajima13 On behalf of the Ja
Autor:
Takashi Himoto, Hiroki Okada, Naohisa Hosomi, Michio Inukai, Fuminori Goda, Hisashi Masugata, Shoichi Senda, Koji Murao
Publikováno v:
Clinical and Experimental Hypertension. 36:258-262
Cardio-ankle vascular index (CAVI) has been demonstrated as a parameter of arterial stiffness, which antihypertensive therapy may improve. However, little information is available about the factors affecting changes in arterial stiffness assessed by